We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Abdullah Abdussalam, MD
Proactive vs. Reactive Therapeutic Drug Monitoring of Infliximab in Crohn’s Disease
Mario R. Nacinovich, Jr., MSc
David Fajgenbaum, MD
Research Efforts in the Race to Find a Cure for COVID-19
Charles Turck, PharmD
Investigating the Circulation of Counterfeit COVID-19 Medications
Matt Birnholz, MD
Frank Scott, MD
2020 Crohn’s & Colitis Congress: How & When to Perform Disease & Drug Monitoring
Linda Bernstein, Pharm.D.
The DEA’s Adjustment to Schedule II Rules Amid COVID-19
John J. Russell, MD
Off-Label Medicines in Fighting COVID-19 & Through the Years
CDC Guidance for Pharmacy Staff on Minimizing Exposure to COVID-19
A Guide for Off-Label Use of Treatments for COVID-19 from the ASHP
Uncovering COVID-19 Treatments: An Update on the SOLIDARITY Trial
REMS-Required Drug Monitoring During the COVID-19 Pandemic
Joshua Sharfstein, MD
COVID-19 & the Potential for Prescription Drug Shortages
Update on Remdesivir, Investigational Antiviral for COVID-19
Chloroquine as a Treatment Agent for COVID-19: Hype or Hope?
Anish Patel, DO, FACG
Real-World Pattern of Biologic Use in Patients with Inflammatory Bowel Disease
Jay L. Koyner, MD
Sandra L. Kane-Gill, PharmD, MS, FCCM, FCCP
John A. Kellum, MD, MCCM
Early Recognition of Acute Kidney Injury: What’s the Role of Biomarkers?
Keeping Pace in Women's Cancer: The Role of PARP Inhibitors in Ovarian Cancer
You need to be logged in to save this episode to a playlist.
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education